Favorable Effects of Inhaled Treprostinil in Severe Pulmonary Hypertension. Results From Randomized Controlled Pilot Studies

Journal of the American College of Cardiology

Volumn 48, Issue 8, 2006, Pages 1672-1681

  Voswinckel, Robert ^a   Enke, Beate ^a   Reichenberger, Frank ^a   Kohstall, Markus ^a   Kreckel, Andree ^a   Krick, Stefanie ^a   Gall, Henning ^a   Gessler, Tobias ^a   Schmehl, Thomas ^a   Ghofrani, Hossein A ^a   Schermuly, Ralph Theo ^a   Grimminger, Friedrich ^a   Rubin, Lewis J ^b   Seeger, Werner ^a   Olschewski, Horst ^a,c  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST; UNIPROST;

ADULT; AGED; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG EFFECT; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FEMALE; FLUSHING; HEART CATHETERIZATION; HUMAN; JAW DISEASE; LOW DRUG DOSE; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; NEBULIZER; PAIN; PILOT STUDY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; TASTE DISORDER; VASODILATATION;

ADMINISTRATION, INHALATION; BLOOD PRESSURE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPOPROSTENOL; HUMANS; HYPERTENSION, PULMONARY; NEBULIZERS AND VAPORIZERS; PILOT PROJECTS; PULMONARY ARTERY; PULMONARY CIRCULATION; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; ULTRASONICS; VASCULAR RESISTANCE; VASODILATION;

EID: 33749537060     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.06.062     Document Type: Article

References (14)

1. Rubin L.J., and Galie N. Pulmonary arterial hypertension: a look to the future. J Am Coll Cardiol 43 (2004) 89S-90S
2. Badesch D.B., McLaughlin V.V., Delcroix M., et al. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 43 (2004) 56S-61S
3. Oudiz R.J., Schilz R.J., Barst R.J., et al. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. Chest 126 (2004) 420-427
4. Gomberg-Maitland M., Tapson V.F., Benza R.L., et al. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. Am J Respir Crit Care Med 172 (2005) 1586-1589
5. Olschewski H., Simonneau G., Galie N., et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347 (2002) 322-329
6. Simonneau G., Barst R.J., Galie N., et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension. A double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 165 (2002) 800-804
7. Laliberte K., Arneson C., Jeffs R., Hunt T., and Wade M. Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers. J Cardiovasc Pharmacol 44 (2004) 209-214
8. Voswinckel R., Ghofrani H.A., Grimminger F., Seeger W., and Olschewski H. Inhaled trepostinil for treatment of chronic pulmonary arterial hypertension. Ann Intern Med 144 (2006) 149-150
9. Wade M., Baker F.J., Roscigno R., et al. Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion. J Clin Pharmacol 44 (2004) 503-509
10. Olschewski H., Rohde B., Behr J., et al. Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension. Chest 124 (2003) 1294-1304
11. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79 (1999) 1193-1226
12. Olschewski H., Rose F., Schermuly R., et al. Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol Ther 102 (2004) 139-153
13. Wade M., Baker F.J., Roscigno R., DellaMaestra W., Hunt T.L., and Lai A.A. Absolute bioavailability and pharmacokinetics of treprostinil sodium administered by acute subcutaneous infusion. J Clin Pharmacol 44 (2004) 83-88
14. McLaughlin V.V., Gaine S.P., Barst R.J., et al. Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. J Cardiovasc Pharmacol 41 (2003) 293-299